ZIVO — Zivo Bioscience Share News
0.000.00%
Last trade - 00:00- $13.08m
- $13.55m
- $0.16m
Brief: Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza
Brief: Zivo Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product
Brief: Zivo Bioscience Announces Reverse Stock Split
Brief: Trial Results Confirm Efficacy Of Zivo Bioscience’S Non-Antibiotic Product Candidate For The Prevention And Treatment Of Coccidiosis In Broiler Chickens
Brief: Zivo Bioscience Files For Offering Of 3 Million Shares Of Common Stock Underlying Series A Common Warrants, Series B Common Warrants By Selling Stockholder
Brief: ZIVO Commences Sales Of Its Proprietary Algal Biomass As Human Food
Brief: Zivo Bioscience Receives Nasdaq Notice Of Delisting Or Failure
Brief: Zivo Bioscience Receives $1 Million Bridge Financing
U.S. STOCKS ON THE MOVE-Meta, Bed Bath & Beyond
Brief: Zivo Bioscience Announces Results Of Study With Its Coccidiosis Drug In Broiler Chickens
Brief: Zivo Bioscience Has Received Notice Of Delisting From Nasdaq
Brief: Zivo Bioscience Establishes Zivolife Agtech Business
Brief: Zivo Bioscience Inc Announces Receipt Of A Letter From The U.S. Department Of Agriculture's Center For Veterinary Biologics
Brief: Zivo Reports That USDA Claims Regulatory Jurisdiction For New Coccidiosis Treatment
Brief: Zivo Bioscience Joins Russell Microcap Index
Brief: Zivo Bioscience Regains Compliance Following Receipt Of Noncompliance Notice From Nasdaq
Brief: Zivo Bioscience Inc Says Co Received An Email From DAHL
Brief: Zivo Bioscience Names Chairman John B. Payne As President And CEO
Brief: Zivo Bioscience - On Nov 30, Wolinetz, Lafazan & Company Resigned As Co's Independent Auditors